Show Summary Details
Page of



Eduardo Duarte Silva

and Olof H. Sundin

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 May 2022

Nanophthalmos is a rare developmental eye disorder that may be inherited in a sporadic, autosomal dominant and autosomal recessive fashion. Nanophthalmos is usually bilateral and symmetrical. Data derived from linkage studies of large pedigrees with nanophthalmos and the identification of genetic mutations as the cause of classic non-syndromic and syndromic (ODDD) nanophthalmos have helped elucidate the pathophysiology of these conditions.

Mutations in the MFRP gene cause autosomal recessive nanophthalmos. The genes associated with the dominant forms of the disease remain unknown. The MFRP gene encodes a glycosylated transmembrane protein with highly conserved domains and is expressed in the RPE and ciliary body. Patients lacking MFRP protein have no obvious-extraocular pathology, suggesting that its function is restricted to ocular development and physiology.15,21

The possibility of serious complications later in the course of disease makes a correct diagnosis of pivotal importance. This will allow the design and implementation of better therapeutic guidelines with improved outcomes in the management of nanophthalmos.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.